Literature DB >> 9726435

Proinflammatory cytokines lowering erythropoietin production.

W Jelkmann1.   

Abstract

The plasma level of erythropoietin (Epo) in anemic patients suffering from inflammation is often low in relation to the blood hemoglobin concentration. Various proinflammatory cytokines have been tested for their action on the synthesis of Epo. Interleukin 1 (IL-1) and tumor necrosis factor-alpha(TNF-alpha) suppress Epo gene expression in isolated perfused rat kidneys and in human hepatoma cell cultures. IL-6 inhibits in the kidney, and conflicting results have been reported for its effect on Epo synthesis in hepatic cells. Several other cytokines tested were without effect. Thus, mainly IL-1 and TNF-alpha seem to be responsible for the defect in Epo production in severe systemic and renal inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9726435     DOI: 10.1089/jir.1998.18.555

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  93 in total

1.  Afebrile Plasmodium falciparum parasitemia decreases absorption of fortification iron but does not affect systemic iron utilization: a double stable-isotope study in young Beninese women.

Authors:  Colin I Cercamondi; Ines M Egli; Ella Ahouandjinou; Romain Dossa; Christophe Zeder; Lamidhi Salami; Harold Tjalsma; Erwin Wiegerinck; Toshihiko Tanno; Richard F Hurrell; Joseph Hounhouigan; Michael B Zimmermann
Journal:  Am J Clin Nutr       Date:  2010-10-06       Impact factor: 7.045

Review 2.  Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy.

Authors:  Cristina Hernández; Rafael Simó
Journal:  Endocrine       Date:  2011-12-14       Impact factor: 3.633

Review 3.  Regulation of erythropoietin production.

Authors:  Wolfgang Jelkmann
Journal:  J Physiol       Date:  2010-11-15       Impact factor: 5.182

4.  Red Cell Distribution Width Predicts 90 Day Mortality in Continuous-Flow Left Ventricular Assist Device Patients.

Authors:  Lauren K Truby; Lakshmi Sridharan; Raul J Flores; A Reshad Garan; Douglas Jennings; Melana Yuzefpolskaya; Koji Takeda; Hiroo Takayama; Yoshifumi Naka; Paolo C Colombo; Veli K Topkara
Journal:  ASAIO J       Date:  2019 Mar/Apr       Impact factor: 2.872

5.  Hip fracture patients who experience a greater fluctuation in RDW during hospital course are at heightened risk for all-cause mortality: a prospective study with 2-year follow-up.

Authors:  P Yin; H Lv; Y Li; Y Meng; L Zhang; L Zhang; P Tang
Journal:  Osteoporos Int       Date:  2018-04-14       Impact factor: 4.507

6.  Pathogenesis and treatment of anemia in inflammatory bowel disease.

Authors:  Günter Weiss; Christoph Gasche
Journal:  Haematologica       Date:  2010-02       Impact factor: 9.941

7.  Anaemia in patients with cancer: role of inflammatory activity on iron metabolism and severity of anaemia.

Authors:  M L V Jacober; R L Mamoni; C S P Lima; B L Dos Anjos; H Z W Grotto
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 8.  Potential immune mechanisms associated with anemia in Plasmodium vivax malaria: a puzzling question.

Authors:  Thiago Castro-Gomes; Luiza C Mourão; Gisely C Melo; Wuelton M Monteiro; Marcus V G Lacerda; Érika M Braga
Journal:  Infect Immun       Date:  2014-08-04       Impact factor: 3.441

9.  The prevalence and evolution of anemia associated with tuberculosis.

Authors:  Sei Won Lee; Young Ae Kang; Young Soon Yoon; Sang-Won Um; Sang Min Lee; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Young-Soo Shim; Jae-Joon Yim
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

10.  Early exposure of infants to GI nematodes induces Th2 dominant immune responses which are unaffected by periodic anthelminthic treatment.

Authors:  Victoria J Wright; Shaali Makame Ame; Haji Said Haji; Rosemary E Weir; David Goodman; David I Pritchard; Mahdi Ramsan Mohamed; Hamad Juma Haji; James M Tielsch; Rebecca J Stoltzfus; Quentin D Bickle
Journal:  PLoS Negl Trop Dis       Date:  2009-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.